Testicular seminoma (pure) – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Thu, 28 May 2026 11:28:23 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Testicular seminoma (pure) – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on the Impact of Cisplatin and Drug Combination on Speech and Cognition in Cancer Patients https://clinicaltrials.eu/trial/study-on-the-impact-of-cisplatin-and-drug-combination-on-speech-and-cognition-in-cancer-patients/ Wed, 29 Apr 2026 15:05:47 +0000 https://clinicaltrials.eu/trial/study-on-the-impact-of-cisplatin-and-drug-combination-on-speech-and-cognition-in-cancer-patients/ This clinical trial is focused on studying the effects of different cancer treatments on how well people can understand speech in noisy environments, as well as their thinking abilities and overall quality of life. The study involves patients diagnosed with cancer who are receiving treatments aimed at curing the disease. The treatments being studied include medications such as cisplatin, oxaliplatin, gemcitabine, capecitabine, mesna, ifosfamide, etoposide, and bleomycin. These medications are administered either through intravenous infusion, which means they are given directly into a vein, or orally in the form of tablets.

The purpose of the study is to assess the short-term effects of these cancer treatments on speech perception in noise. Participants will undergo various assessments to measure changes in their ability to understand speech in noisy settings, as well as changes in their hearing and cognitive functions. The study will also evaluate the impact of these treatments on the participants’ quality of life related to hearing. The trial will follow participants from the start of their treatment and include follow-up visits to monitor any changes over time.

By participating in this study, researchers aim to gain a better understanding of how cancer treatments affect important aspects of daily life, such as communication and cognitive abilities. This information could help improve future treatment plans and support services for individuals undergoing cancer therapy. The study is expected to continue until the end of 2031, with recruitment starting in August 2024.

]]>